Emphasizing ease of installation and a cloud-based service, Cleerly said its new Proxy software allows smooth transmission of coronary computed tomography angiography (CCTA) scans between interdisciplinary clinicians caring for patients with heart disease.
As a possible alternative to navigating the intricacies of different systems and radiology workflows at multiple facilities, Cleerly has launched Proxy software that provides automated transmission of coronary computed tomography angiography (CCTA) scans from local facility systems to a cloud-based service.
The company said Proxy can be utilized for the receipt of CCTA scans from multiple imaging and vendor neutral archive (VNA) modalities as well as picture archiving and communication systems (PACS). Clinicians can subsequently obtain the CCTA scans from the Cleerly cloud service to review the imaging findings or discuss results with patients.
Distributed as an open visualization appliance (OVA) file, Proxy can reportedly be installed and launched in five minutes, according to Cleerly.
Cleerly added that the setup for Proxy includes access to remote implementation specialists for questions regarding Proxy configuration, testing and initial use of digital imaging and communications medicine (DICOM) uploads.
“With Proxy, our goal is to be completely seamless and allow providers to better treat their heart patients,” noted James Min, M.D., FACC, FESC, MSCCT, the founder and CEO of Cleerly. “The addition of Proxy to our portfolio will decrease the time in which providers receive our (artificial intelligence) AI-based quantifiable disease analysis with a tool that fits directly into their workflows. This virtual appliance is another way we are improving how heart disease is identified, prevented, and treated.”
(Editor's note: For related articles, see "Deep Learning Improves CT Guidance for Revascularization of Coronary Total Occlusions" and "HeartFlow Garners FDA Clearance for Two AI-Powered Tools with CCTA.")
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.